These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33768726)

  • 1. Lifestyle changes and their impact on glycemic control and weight control in patients with diabetes during the coronavirus disease 2019 pandemic in Japan.
    Takahara M; Watanabe H; Shiraiwa T; Maeno Y; Yamamoto K; Shiraiwa Y; Yoshida Y; Nishioka N; Katakami N; Shimomura I
    J Diabetes Investig; 2022 Feb; 13(2):375-385. PubMed ID: 33768726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 Pandemic on Glycemic Control and Blood Pressure Control in Patients with Diabetes in Japan.
    Endo K; Miki T; Itoh T; Kubo H; Ito R; Ohno K; Hotta H; Kato N; Matsumoto T; Kitamura A; Tamayama M; Wataya T; Yamaya A; Ishikawa R; Ooiwa H
    Intern Med; 2022; 61(1):37-48. PubMed ID: 34980759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of gender differences on lifestyle and glycemic control in Japanese patients with diabetes during COVID-19 lockdowns.
    Shikuma J; Nagai Y; Sakurai M; Udagawa K; Ito R; Miwa T; Suzuki R
    Prim Care Diabetes; 2022 Jun; 16(3):350-354. PubMed ID: 35283067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle changes as a result of COVID-19 containment measures: Bodyweight and glycemic control in patients with diabetes in the Japanese declaration of a state of emergency.
    Tanaka N; Hamamoto Y; Kurotobi Y; Yamasaki Y; Nakatani S; Matsubara M; Haraguchi T; Yamaguchi Y; Izumi K; Fujita Y; Kuwata H; Hyo T; Yamada Y; Kurose T; Seino Y
    J Diabetes Investig; 2021 Sep; 12(9):1718-1722. PubMed ID: 33599073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preserved seasonal variation in glycemic control in patients with type 2 diabetes mellitus during COVID-19: a 3-year-long retrospective cohort study in older adults in Japan.
    Iwata S; Ashida K; Demiya M; Nagayama A; Hasuzawa N; Yoshinobu S; Sonezaki A; Yasuda J; Motomura S; Katsuki Y; Sugi K; Nomura M
    BMC Endocr Disord; 2024 May; 24(1):70. PubMed ID: 38755559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living and working environments are important determinants of glycemic control in patients with diabetes during the COVID-19 pandemic: A retrospective observational study.
    Terakawa A; Bouchi R; Kodani N; Hisatake T; Sugiyama T; Matsumoto M; Ihana-Sugiyama N; Ohsugi M; Ueki K; Kajio H
    J Diabetes Investig; 2022 Jun; 13(6):1094-1104. PubMed ID: 35088564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Year-long effects of COVID-19 restrictions on glycemic control and body composition in patients with glucose intolerance in Japan: A single-center retrospective study.
    Tsukaguchi R; Murakami T; Yoshiji S; Shide K; Fujita Y; Ogura M; Inagaki N
    J Diabetes Investig; 2022 Dec; 13(12):2063-2072. PubMed ID: 35980313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes management by either telemedicine or clinic visit improved glycemic control during the coronavirus disease 2019 pandemic state of emergency in Japan.
    Onishi Y; Yoshida Y; Takao T; Tahara T; Kikuchi T; Kobori T; Kubota T; Shimmei A; Iwamoto M; Kasuga M
    J Diabetes Investig; 2022 Feb; 13(2):386-390. PubMed ID: 33728760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of coronavirus disease 2019 pandemic on the lifestyle and glycemic control in patients with type 2 diabetes: a cross-section and retrospective cohort study.
    Munekawa C; Hosomi Y; Hashimoto Y; Okamura T; Takahashi F; Kawano R; Nakajima H; Osaka T; Okada H; Majima S; Senmaru T; Nakanishi N; Ushigome E; Hamaguchi M; Yamazaki M; Fukui M
    Endocr J; 2021 Feb; 68(2):201-210. PubMed ID: 32999133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the State of Emergency Declaration for Severe Acute Respiratory Syndrome Coronavirus-2 Pandemic Suppression on Individuals with Type 1 Diabetes Mellitus.
    Mochizuki S; Miura J; Takagi S; Takita M; Takaike H; Babazono T
    Intern Med; 2024 May; 63(9):1197-1205. PubMed ID: 38369358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of COVID-19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: A multicenter retrospective observational study.
    Bouchi R; Sugiyama T; Goto A; Ohsugi M; Yoshioka N; Katagiri H; Mita T; Hirota Y; Ikegami H; Matsuhisa M; Araki E; Yokoyama H; Minami M; Yamazaki K; Jinnouchi H; Ikeda H; Fujii H; Nogawa M; Kaneshige M; Miyo K; Ueki K
    J Diabetes Investig; 2023 Aug; 14(8):994-1004. PubMed ID: 37183588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: A hospital-based cross-sectional survey from South India.
    Sankar P; Ahmed WN; Mariam Koshy V; Jacob R; Sasidharan S
    Diabetes Metab Syndr; 2020; 14(6):1815-1819. PubMed ID: 32956926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medium-term Influence of the Coronavirus Disease 2019 Pandemic on Patients with Diabetes: A Single-center Cross-sectional Study.
    Maruo Y; Irie Y; Obata Y; Takayama K; Yamaguchi H; Kosugi M; Hazama Y; Yasuda T
    Intern Med; 2022 Feb; 61(3):303-311. PubMed ID: 34803093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the COVID-19 pandemic on the glycemic control, eating habits, and body compositions of people with diabetes mellitus: A retrospective longitudinal observational study.
    Sawada M; Ohkuma K; Aihara M; Doi S; Sekine R; Kaneko T; Iimuro S; Ichi I; Usami S; Ohe K; Yamauchi T; Kubota N
    J Diabetes Investig; 2023 Feb; 14(2):321-328. PubMed ID: 36346131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of COVID-19 lockdown on glycaemic control and lifestyle changes in children and adolescents with type 1 and type 2 diabetes mellitus.
    Cheng HP; Wong JSL; Selveindran NM; Hong JYH
    Endocrine; 2021 Sep; 73(3):499-506. PubMed ID: 34244903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown.
    Tanji Y; Sawada S; Watanabe T; Mita T; Kobayashi Y; Murakami T; Metoki H; Akai H
    Diabetes Res Clin Pract; 2021 Jun; 176():108840. PubMed ID: 33933499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight change and glycemic control in type 2 diabetes patients during COVID-19 pandemic: the lockdown effect.
    Biamonte E; Pegoraro F; Carrone F; Facchi I; Favacchio G; Lania AG; Mazziotti G; Mirani M
    Endocrine; 2021 Jun; 72(3):604-610. PubMed ID: 33950348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic Control and Mucormycosis during COVID-19 Pandemic in India a Study of Stage and Outcome.
    Sharma V; Kriplani K; Tuli IP; Sharma S; Narula A
    J Assoc Physicians India; 2023 Sep; 71(9):61-66. PubMed ID: 38700303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of lockdown caused by the COVID-19 pandemic on glycemic control in patients with diabetes.
    Sutkowska E; Marciniak DM; Sutkowska K; Biernat K; Mazurek J; Kuciel N
    Endocrine; 2022 May; 76(2):273-281. PubMed ID: 35072900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification effect of receipt of diabetes care on the association between COVID-19 infection and HbA1c level during the first year of the coronavirus pandemic using a nationwide population-based database.
    Okada A; Yamaguchi S; Ono S; Kurakawa KI; Yasunaga H; Nangaku M; Yamauchi T; Kadowaki T
    J Diabetes Investig; 2024 Jul; 15(7):953-963. PubMed ID: 38429979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.